Best Biotech Stocks

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by...

1d ago

ADMA

BCRX

BioNTech price target raised to $113 from $107 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns raised the firm’s price target on BioNTech to $113 from $107 and keeps...

1d ago

BNTX

Drugmakers work to make treatments to maintain weight loss, WSJ reports

After the success of weight loss drugs, including Novo Nordisk’s (NVO) Ozempic and Wegovy, researchers are now testing...

1d ago

LLY

NVO

Regeneron reports positive results from DB-OTO study

Regeneron Pharmaceuticals announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed...

1d ago

Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks

Preliminary data detailed in an ASGCT oral presentation include results for one of the youngest children in the...

1d ago

Vertex Pharmaceuticals price target raised to $477 from $466 at UBS

UBS raised the firm’s price target on Vertex Pharmaceuticals to $477 from $466 and keeps a Buy rating...

2d ago

Gilead put volume heavy and directionally bearish

Bearish flow noted in Gilead with 23,142 puts trading, or 1.7x expected. Most active are May-24 72.5 puts...

2d ago

GILD

Vertex Pharmaceuticals price target raised to $529 from $511 at Leerink

Leerink raised the firm’s price target on Vertex Pharmaceuticals to $529 from $511 and keeps an Outperform rating...

2d ago

Illumina divestiture of GRAIL would be positive, says Canaccord

Canaccord reiterated a Hold rating on Illumina and maintained the firm’s price target of $130 after the company...

2d ago

ILMN

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

AMGN

Amgen

Hold

Reiterated

2024-05-09

BNTX

BioNTech SE

Hold

Reiterated

2024-05-08

Vertex Pharmaceuticals

Hold

Reiterated

2024-05-08

IQV

IQVIA Holdings

Buy

Reiterated

2024-05-08

MRNA

Moderna

Buy

Assigned

2024-05-08

ILMN

Illumina

Buy

Reiterated

2024-05-07

Regeneron

Buy

Reiterated

2024-05-06

BIIB

Biogen

Buy

Reiterated

2024-05-03

GILD

Gilead Sciences

Buy

Reiterated

2024-05-01

IQV

IQVIA Holdings

Buy

Reiterated

2024-05-08

All Ratings >

Most Recent Earnings of Biotech Stocks

GILD

Gilead Sciences

Apr 25, 2024

Mar 01, 2024

-1.49 / -1.32

1.34

AMGN

Amgen

May 02, 2024

Mar 01, 2024

3.88 / 3.96

Vertex Pharmaceuticals

May 06, 2024

Mar 01, 2024

4.07 / 4.76

3.89

BIIB

Biogen

Apr 24, 2024

Mar 01, 2024

3.47 / 3.67

4.02

ILMN

Illumina

May 02, 2024

Mar 01, 2024

0.04 / 0.09

0.32

Regeneron

May 02, 2024

Mar 01, 2024

10.17 / 9.55

10.24

MRNA

Moderna

May 02, 2024

Mar 01, 2024

-3.56 / -3.07

-3.62

IQV

IQVIA Holdings

May 02, 2024

Mar 01, 2024

2.49 / 2.54

2.43

BNTX

BioNTech SE

May 06, 2024

Mar 01, 2024

-1.34 / -1.41

-0.79

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

IQVIA Holdings - Strong Buy, based on 17 analyst ratings, 15 Buy, 2 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $64.67, and its average 12-month price target is $81.79.

Amgen's stock price is currently $313.84, and its average 12-month price target is $322.00.

Vertex Pharmaceuticals's stock price is currently $419.15, and its average 12-month price target is $458.19.

Biogen's stock price is currently $221.80, and its average 12-month price target is $287.33.

Illumina's stock price is currently $111.08, and its average 12-month price target is $156.69.

Regeneron's stock price is currently $969.30, and its average 12-month price target is $1,050.65.

Moderna's stock price is currently $123.08, and its average 12-month price target is $134.00.

IQVIA Holdings's stock price is currently $229.23, and its average 12-month price target is $278.40.

BioNTech SE's stock price is currently $92.01, and its average 12-month price target is $112.70.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.77 which represents an annual dividend yield of 4.65%. Gilead Sciences's next Ex-dividend date is June 14, 2024 and its next payout date is June 27, 2024.

Amgen currently pays a dividend of $2.25 which represents an annual dividend yield of 2.81%. Amgen's next Ex-dividend date is May 16, 2024 and its next payout date is June 7, 2024.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

BioNTech SE does not currently pay dividends.

Latest News

Next-Gen Obesity Drugs Gives Novo Nordisk (NYSE:NVO) a Lift

NOVO

El Pollo Loco (NASDAQ:LOCO): A Restaurant in Its Early Growth Stage

LOCO

Netflix (NASDAQ:NFLX) May Bid for Christmas Day NFL Rights

NFLX

RBLX

Sky Is Falling at Boeing (NYSE:BA), Shares Up Anyway

SPR

GBP-USD Little Changed as BOE Hold Rates Steady

BITCOIN

McDonald’s (NYSE:MCD) Backs Franchisees with Digital Marketing Fund

MCD

Forex Volatility Tool: Bollinger Bands

Arm Holdings (NASDAQ:ARM) Plunges as Guidance Fails to Impress

ARM

NVDA

Canada Goose (TSE:GOOS) Gets Plucked as Securities Violations Emerge

GOOS

M&A News: GOOGL Could Be in Advanced Talks With HubSpot

GOOG

HUBS

Cardano Foundation Brings New CTO For Growth

UBS

DUOL Earnings: Duolingo Tanks After Subscriber Growth Concerns

DUOL

YETI Earnings: YETI Skyrockets After Hiking Outlook

YETI

WBD Earnings: Warner Bros. Discovery’s Q1 Results Disappoint

WBD